Parmax Pharma Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Parmax Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
26.55% Gain from 52W Low
0.1
TTM PE Ratio
Negative PE TTM
-2.8
Price to Book Ratio
Low in industry
1.7
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
48.9
MFI
MFI is mid-range
45.7

Parmax Pharma Ltd shareholding Pattern

Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Parmax Pharma Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
30.90
10Day EMA
31.00
12Day EMA
31.00
20Day EMA
31.00
26Day EMA
30.90
50Day EMA
30.80
100Day EMA
31.00
200Day EMA
31.20
5Day SMA
31.10
10Day SMA
31.00
20Day SMA
31.00
30Day SMA
30.80
50Day SMA
30.40
100Day SMA
31.30
150Day SMA
31.20
200Day SMA
30.90
Delivery & Volume
Resistance & Support
30.93
Pivot
Resistance
First Resistance
31.57
Second Resistance
32.53
Third Resistance
33.17
Support
First Support
29.97
Second support
29.33
Third Support
28.37
Relative Strength Index
48.92
Money Flow Index
45.72
MACD
0.12
MACD Signal
0.20
Average True Range
2.80
Average Directional Index
35.83
Rate of Change (21)
2.68
Rate of Change (125)
-0.36
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Chemo Pharma Laboratories Ltd.
-
-
-
Span Divergent Ltd.
-
-
-
Kobo Biotech Ltd.
-
-
-
Unjha Formulations Ltd.
-
-
-
Ganga Pharmaceuticals Ltd.
-
-
-
Adline Chem Lab Ltd.
-
-
-
Parmax Pharma Ltd.
-
-
-

Parmax Pharma Ltd Company background

Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Read More

Parmax Pharma Ltd FAQs

You can easily buy Parmax Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage